Reutens AT, Jandeleit-Dahm K, Thomas M et al (2020) A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: protocol and statistical considerations
Beyond its primary GLP-1 metabolic platform, SureNano Science is also evaluating early-stage opportunities that could expand the long-term scope of its therapeutic and delivery technology portfolio
Athletes have used meldonium to enhance recovery and (controversially) performance, though these claims lack robust scientific support
The association between melatonin and increased risk of heart failure or death found in this study, while not confirming a cause-and-effect relationship, raises safety concerns about the widespread use of melatonin
Report all side effects to your provider
It also ran counter to the conservative North Carolina environment in which Hall grew up